Sagital Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.18 M
as on 13-12-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Sagital Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Verma, Manoj Sabharwal, Vipin Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232UP2004PTC028833
- Company No.
028833
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationEtah, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sagital Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praja Palan  | Managing Director | 07-Jul-2004 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Verma | Director | 07-Jul-2004 | Current |
| Manoj Sabharwal | Director | 07-Jul-2004 | Current |
| Vipin Kumar | Director | 07-Jul-2004 | Current |
| Sandeep Rajput | Director | 07-Jul-2004 | Current |
Financial Performance of Sagital Pharmaceutical.
Sagital Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sagital Pharmaceutical?
In 2017, Sagital Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ganga Vidhya Property Hub Private LimitedActive 11 years 6 monthsSudhir Verma, Vipin Kumar and 1 more are mutual person
- Ganga Vidhya Finance LimitedActive 35 years 2 months
Sudhir Verma, Vipin Kumar and 1 more are mutual person
- Ganga Prasad Sheet Grah Private LimitedActive 35 years 9 months
Vipin Kumar and Praja Palan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sagital Pharmaceutical?
Unlock and access historical data on people associated with Sagital Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagital Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagital Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
